US3853893A
(en)
*
|
1973-04-02 |
1974-12-10 |
Squibb & Sons Inc |
Anthelmintic 5-(pyridyl)-3-(isothiocyanophenyl) oxadiazoles
|
HU177086B
(en)
*
|
1975-06-09 |
1981-07-28 |
Eszakmagyar Vegyimuevek |
Herbicide and fungicide preparation containing substituted 1,2,4-oxadiazolidin-3-one derivatives
|
JPS58150576A
(ja)
*
|
1982-03-03 |
1983-09-07 |
Sumitomo Chem Co Ltd |
新規な1,2,4−オキサジアゾ−ル誘導体
|
DE3247118A1
(de)
*
|
1982-12-20 |
1984-06-20 |
Cassella Ag, 6000 Frankfurt |
Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
EP1210344B1
(en)
*
|
1999-08-19 |
2005-10-19 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
US6660753B2
(en)
*
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
EP1582519A3
(en)
*
|
1999-08-19 |
2005-12-21 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
ATE375340T1
(de)
*
|
2001-02-21 |
2007-10-15 |
Nps Pharma Inc |
Heteropolycyclische verbindungen und deren verwendung als metabotrope glutamatrezeptorantagonisten
|
AU2003264018A1
(en)
|
2002-08-09 |
2004-02-25 |
Astrazeneca Ab |
Compounds having an activity at metabotropic glutamate receptors
|
WO2004091480A2
(en)
*
|
2003-04-09 |
2004-10-28 |
Exelixis, Inc. |
Tie-2 modulators and methods of use
|
AU2004240586A1
(en)
*
|
2003-05-15 |
2004-12-02 |
Merck & Co., Inc. |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as S1P receptor agonists
|
US20060189661A1
(en)
*
|
2003-11-03 |
2006-08-24 |
Wagenen Bradford V |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
WO2005060961A2
(en)
*
|
2003-12-18 |
2005-07-07 |
Astrazeneca Ab |
Treatment of transient lower esophageal sphincter relaxations (tlesrs) and gastro-esophageal reflux disease (gerd)
|
KR101154830B1
(ko)
*
|
2003-12-24 |
2012-06-18 |
프로시디온 리미티드 |
Gpcr 수용체 효능제로서의 헤테로사이클릭 유도체
|
WO2005077368A2
(en)
*
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
CA2606087A1
(en)
|
2005-04-26 |
2006-11-02 |
Neurosearch A/S |
Novel oxadiazole derivatives and their medical use
|
IL169855A
(en)
*
|
2005-07-25 |
2014-05-28 |
Elta Systems Ltd |
A system and method for locating a receiver location
|
US8168793B2
(en)
|
2005-07-26 |
2012-05-01 |
Portela & Ca., S.A. |
Nitrocatechol derivatives as COMT inhibitors
|
EP1845097A1
(en)
|
2006-04-10 |
2007-10-17 |
Portela & Ca., S.A. |
Oxadiazole derivatives as COMT inhibitors
|
RU2447071C2
(ru)
*
|
2006-09-07 |
2012-04-10 |
Актелион Фармасьютиклз Лтд |
Производные пиридин-4-ила в качестве иммуномодулирующих агентов
|
ES2400163T3
(es)
*
|
2006-09-08 |
2013-04-08 |
Actelion Pharmaceuticals Ltd. |
Derivados de piridil-3-ilo como agentes de inmunomodulación
|
US8524746B2
(en)
|
2007-01-31 |
2013-09-03 |
Bial-Portela & Ca., S.A. |
Dosage regimen for COMT inhibitors
|
PL2125797T3
(pl)
*
|
2007-03-16 |
2014-06-30 |
Actelion Pharmaceuticals Ltd |
Pochodne aminopirydyny jako agoniści receptora S1P1/EDG1
|
MY153975A
(en)
*
|
2007-08-17 |
2015-04-30 |
Actelion Pharmaceuticals Ltd |
Pyridine derivatives as s1p1/edg1 receptor modulators
|
BRPI0908340A2
(pt)
*
|
2008-02-28 |
2018-12-26 |
Bial Portela & Ca Sa |
composição farmacêutica para fármacos pouco solúveis
|
EP2262799B1
(en)
*
|
2008-03-06 |
2012-07-04 |
Actelion Pharmaceuticals Ltd. |
Pyridine compounds
|
US8575200B2
(en)
*
|
2008-03-07 |
2013-11-05 |
Actelion Pharmaceuticals Ltd |
Pyridin-2-yl derivatives as immunomodulating agents
|
JP2011514380A
(ja)
|
2008-03-17 |
2011-05-06 |
バイアル−ポルテラ アンド シーエー,エス.エー. |
5−[3−(2,5−ジクロロ−4,6−ジメチル−1−オキシ−ピリジン−3−イル)[1,2,4]オキサジアゾール−5−イル]−3−ニトロベンゼン−1,2−ジオールの結晶形
|
FI2291080T5
(fi)
|
2008-05-14 |
2023-11-06 |
The Scripps Research Institute |
Uusia sfingosiinifosfaattireseptorimodulaattoreita
|
US8017555B2
(en)
|
2009-02-10 |
2011-09-13 |
Divergence, Inc. |
Compositions and methods for controlling nematodes
|
EP2413913B1
(en)
*
|
2009-04-01 |
2022-05-18 |
Bial-Portela & CA, S.A. |
Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
|
KR20120027197A
(ko)
|
2009-04-01 |
2012-03-21 |
바이알 - 포르텔라 앤드 씨에이 에스에이 |
니트로카테콜 유도체를 포함하는 제약 제제 및 그의 제조 방법
|
EP2454255B1
(en)
|
2009-07-16 |
2013-11-06 |
Actelion Pharmaceuticals Ltd. |
Pyridin-4-yl derivatives as s1p1/edg1 agonists
|
JP5859570B2
(ja)
|
2011-01-19 |
2016-02-10 |
アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd |
2−メトキシ−ピリジン−4−イル誘導体
|
US20140045900A1
(en)
|
2011-02-11 |
2014-02-13 |
Bial-Portela & Ca, S.A. |
Administration regime for nitrocatechols
|
WO2013089573A1
(en)
|
2011-12-13 |
2013-06-20 |
BIAL - PORTELA & Cª., S.A. |
Chemical compound useful as intermediate for preparing a catechol-o-methyltransferase inhibitor
|
UY35327A
(es)
*
|
2013-02-15 |
2014-09-30 |
Monsanto Technology Llc |
?4,5-dihidro-1,2,4-oxadiazoles disustituidos en 3,5 y composiciones y métodos para controlar plagas de nematodos?.
|
JP2018500300A
(ja)
|
2014-11-28 |
2018-01-11 |
ノヴィファーマ,エス.アー. |
パーキンソン病を遅延させるための医薬
|
KR20200044155A
(ko)
|
2015-05-20 |
2020-04-28 |
이도르시아 파마슈티컬스 리미티드 |
화합물 (s)-3-{4-[5-(2-시클로펜틸-6-메톡시-피리딘-4-일)-[1,2,4]옥사디아졸-3-일]-2-에틸-6-메틸-페녹시}-프로판-1,2-디올의 결정형
|